29 December 2025

Awareness Circular – Waring about using the falsified lots of IBRANCE (palbociclib) product.

Reference: CIR-2025-00000237

Awareness Circular – Waring about using the falsified lots of IBRANCE (palbociclib) product.

To all Health facilities and healthcare practitioners in Dubai's private health sector

Referring to the above subject, DHA notifies all health facilities regarding the circulars issued by the MOHAP for perusal and adherence to what is stated.

Circular  No.  (26) for the year 2025 Waring about using the falsified lots of IBRANCE (palbociclib) product.

Thanks in advance for your good co-operation

 

Drug Control Section

Health Regulation Sector

DHA

Supporting Documents:

Awareness Circular no 26 – Waring about using the falsified lots of IBRANCE (palbociclib) product.pdf:

View Document